Catalent Adds Prefilled Syringe Line for Clinical Trial Supplies
Catalent's addition of an automated prefilled syringe clinical packaging line at its Philadelphia facility will support its work with Eli Lilly.
Catalent has announced that it will install automated prefilled syringe clinical packaging lines at its Philadelphia Clinical Supply Center of Excellence, in support of the growth of its strategic partner, Eli Lilly. Catalent currently has automated prefilled syringe packaging capabilities in its clinical supply facility in Schorndorf, Germany
The packaging line is capable of the automated insertion of plunger rods, application of randomized and non-randomized labels and back-stop clips, and off-line labeling with booklet labels. This investment reflects a strong commitment from both Catalent and Eli Lilly to continue shared growth strategies, risks, and to build a long-term strategic partnership, Catalent reports in a press statement.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
